Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

British Biotech and Dr. Millar Settle Their Disputes.


OXFORD, England--(BUSINESS WIRE)--June 8, 1999--

British Biotech British Biotech was a British based biotech company.

British Biotechnology Limited was founded in 1986 by former G D Searle managers Keith McCullagh and Brian Richards, [1]
 plc, British Biotech Pharmaceuticals Limited and Dr. Andrew Millar are pleased to announce that the litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 between them has been settled on terms satisfactory to both parties.

British Biotech have withdrawn their claims and allegations of improper
In mathematics
  • Improper rotation
  • Improper integral
  • Improper fraction
  • Improper prior
  • Improper distribution
  • Improper point
  • Improper limits
Other
  • Improper English
  • Improper motion
  • Improper noun
 behavior and Dr. Millar has agreed not to continue with his proceedings against British Biotech. The terms of the settlement include an appropriate payment to Dr. Millar, the sum of which remains confidential.

British Biotech recognizes that Dr. Millar has always acted in accordance Accordance is Bible Study Software for Macintosh developed by OakTree Software, Inc.[]

As well as a standalone program, it is the base software packaged by Zondervan in their Bible Study suites for Macintosh.
 with his medical opinion, his professional obligations to patients involved in clinical trials, his conscience conscience, sense of moral awareness or of right and wrong. The concept has been variously explained by moralists and philosophers. In the history of ethics, the conscience has been looked upon as the will of a divine power expressing itself in man's judgments, an  and his view of the best interests of British Biotech.

The parties believe that this settlement provides an opportunity for each of them to draw this episode to a close and to concentrate on their respective futures.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUUK
Date:Jun 8, 1999
Words:142
Previous Article:US-Style.com Debut On Yahoo!Japan; Major Promotion Provides US Online Retail Partners Large-scale Exposure to Japanese Market.
Next Article:Tesoro Announces Bolivian and U.S. Discoveries.
Topics:



Related Articles
New ways of doing business in Appeals.
MORE BIOTECH BATTLES.
PINS SHINIER THAN DIAMOND FOR THIS MILLAR, PATH TO PROS ON LANES, NOT BASEPATHS.
Minding the Store.
MILLAR TIME FOR U.S. VOLLEYBALL ON A TEAM THAT HAS STRUGGLED RECENTLY, THE PALMDALE PRODUCT LEADS A TALENTED AMERICAN SQUAD THAT'S BENT ON RECLAIMING...
AMGEN ORDERED TO PAY $205 MILLION.
AMGEN RIVALS GET OK FOR DRUG TESTING.
COUPLE SETTLES FLAP OVER GRINCH SIGN.
FDA CLEARS THROMBOLYTIC DRUG FOR PHASE II CLINICAL TRIAL.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles